» Articles » PMID: 31586053

Arctigenin Attenuates Diabetic Kidney Disease Through the Activation of PP2A in Podocytes

Overview
Journal Nat Commun
Specialty Biology
Date 2019 Oct 6
PMID 31586053
Citations 63
Authors
Affiliations
Soon will be listed here.
Abstract

Arctigenin (ATG) is a major component of Fructus Arctii, a traditional herbal remedy that reduced proteinuria in diabetic patients. However, whether ATG specifically provides renoprotection in DKD is not known. Here we report that ATG administration is sufficient to attenuate proteinuria and podocyte injury in mouse models of diabetes. Transcriptomic analysis of diabetic mouse glomeruli showed that cell adhesion and inflammation are two key pathways affected by ATG treatment, and mass spectrometry analysis identified protein phosphatase 2 A (PP2A) as one of the top ATG-interacting proteins in renal cells. Enhanced PP2A activity by ATG reduces p65 NF-κB-mediated inflammatory response and high glucose-induced migration in cultured podocytes via interaction with Drebrin-1. Importantly, podocyte-specific Pp2a deletion in mice exacerbates DKD injury and abrogates the ATG-mediated renoprotection. Collectively, our results demonstrate a renoprotective mechanism of ATG via PP2A activation and establish PP2A as a potential target for DKD progression.

Citing Articles

Global trends and prospects related to macrophage in chronic kidney disease: a bibliometric analysis.

Hu Y, Wang Y, Hong H, Chen Y, Zhou Q, Zhu G Ren Fail. 2024; 46(2):2423846.

PMID: 39572163 PMC: 11583328. DOI: 10.1080/0886022X.2024.2423846.


Fructus Arctii Mitigates Depressive Disorder via the Let-7e-Modulated Toll-Like Receptor (TLR) Signaling Pathway.

Zhang W, Zhou Q Brain Behav. 2024; 14(11):e70132.

PMID: 39538967 PMC: 11560858. DOI: 10.1002/brb3.70132.


β-Sitosterol Mitigates Apoptosis, Oxidative Stress and Inflammatory Response by Inactivating TLR4/NF-кB Pathway in Cell Models of Diabetic Nephropathy.

Yang S, Zhang Y, Zheng C Cell Biochem Biophys. 2024; 83(1):1249-1262.

PMID: 39424766 DOI: 10.1007/s12013-024-01559-4.


Mechanisms of hepatic and renal injury in lipid metabolism disorders in metabolic syndrome.

Rong J, Zhang Z, Peng X, Li P, Zhao T, Zhong Y Int J Biol Sci. 2024; 20(12):4783-4798.

PMID: 39309427 PMC: 11414397. DOI: 10.7150/ijbs.100394.


Predicting prospective therapeutic targets of Bombyx batryticatus for managing diabetic kidney disease through network pharmacology analysis.

Chang J, Wang J, Li X, Zhong Y Medicine (Baltimore). 2024; 103(37):e39598.

PMID: 39287308 PMC: 11404872. DOI: 10.1097/MD.0000000000039598.


References
1.
Hsieh C, Hsiao G, Hsu M, Wang Y, Sheu J . PMC, a potent hydrophilic α-tocopherol derivative, inhibits NF-κB activation via PP2A but not IκBα-dependent signals in vascular smooth muscle cells. J Cell Mol Med. 2014; 18(7):1278-89. PMC: 4124013. DOI: 10.1111/jcmm.12277. View

2.
Sun Y, Zang Z, Zhong L, Wu M, Su Q, Gao X . Identification of adiponectin receptor agonist utilizing a fluorescence polarization based high throughput assay. PLoS One. 2013; 8(5):e63354. PMC: 3653934. DOI: 10.1371/journal.pone.0063354. View

3.
Yang J, Fan G, Wadzinski B, Sakurai H, Richmond A . Protein phosphatase 2A interacts with and directly dephosphorylates RelA. J Biol Chem. 2001; 276(51):47828-33. PMC: 2665282. DOI: 10.1074/jbc.M106103200. View

4.
Zhang W, Jiang Z, He B, Liu X . Arctigenin Protects against Lipopolysaccharide-Induced Pulmonary Oxidative Stress and Inflammation in a Mouse Model via Suppression of MAPK, HO-1, and iNOS Signaling. Inflammation. 2015; 38(4):1406-14. PMC: 7102291. DOI: 10.1007/s10753-015-0115-3. View

5.
Crispin J, Apostolidis S, Rosetti F, Keszei M, Wang N, Terhorst C . Cutting edge: protein phosphatase 2A confers susceptibility to autoimmune disease through an IL-17-dependent mechanism. J Immunol. 2012; 188(8):3567-71. PMC: 3324672. DOI: 10.4049/jimmunol.1200143. View